Protective Role of Black Tea Extract against Nonalcoholic Steatohepatitis-Induced Skeletal Dysfunction

Protective Role of Black Tea Extract against Nonalcoholic Steatohepatitis-Induced Skeletal Dysfunction

Aim. This paper aimed to examine the chemoprotective actions of aqueous black tea extract (BTE) against nonalcoholic steatohepatitis- (NASH-) induced skeletal changes in rats. Material. Wistar rats (body wt. 155–175 g) of both sexes, aged 4–5 months, were randomly assigned to 3 groups; Group A (cont...

Full description

Saved in:

Bibliographic Details
Main Authors:	Subhra Karmakar, Sangita Majumdar, Anasuya Maiti, Monalisa Choudhury, Aniruddha Ghosh, Asankur S. Das, Chandan Mitra
Format:	Article
Language:	English
Published:	Wiley 2011-01-01
Series:	Journal of Osteoporosis
Online Access:	http://dx.doi.org/10.4061/2011/426863
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Black Tea May Be a Prospective Adjunct for Calcium Supplementation to Prevent Early Menopausal Bone Loss in a Rat Model of Osteoporosis
by: Asankur Sekhar Das, et al.
Published: (2013-01-01)

Nonalcoholic Steatohepatitis in Nondiabetic Obese Patients
by: Idilio Zamin, et al.
Published: (2002-01-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
by: S. Gitto, et al.
Published: (2015-01-01)

Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis
by: Murat Kiyici, et al.
Published: (2003-01-01)

CISD2-mediated mitochondrial dysfunction and iron redistribution contributes to ferroptosis in arsenic-induced nonalcoholic steatohepatitis
by: Jingyuan Zhang, et al.
Published: (2025-01-01)

Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis
by: Onur Baser, et al.
Published: (2024-09-01)

Nonalcoholic Steatohepatitis: More Than Just Being Fat
by: Eldon A Shaffer
Published: (2002-01-01)

LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis
by: Yasuka Matsunaga, et al.
Published: (2015-01-01)

Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
by: Hannes Hagström, et al.
Published: (2018-01-01)

The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis
by: Vajiheh Rangboo, et al.
Published: (2016-01-01)

Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis
by: Stefania Bruno, et al.
Published: (2019-01-01)

Central Portalization Correlates with Fibrosis but Not with Risk Factors for Nonalcoholic Steatohepatitis in Steatotic Chronic Hepatitis C
by: Hwajeong Lee, et al.
Published: (2014-01-01)

The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients
by: I. V. Mayev, et al.
Published: (2013-03-01)

Mouse Models of Nonalcoholic Steatohepatitis: Head-to-Head Comparison of Dietary Models and Impact on Inflammation and Animal Welfare
by: Andreas Kroh, et al.
Published: (2020-01-01)

Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments
by: Beihui He, et al.
Published: (2022-01-01)

Effects of Metabolic Dysfunction–Associated Steatohepatitis in Alertness, Associative Learning, and Astrocyte Density
by: Sara G. Higarza, et al.
Published: (2025-01-01)

Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in 2024: From resmetirom to tirzepatide
by: Rui Huang, et al.
Published: (2025-01-01)

The AMPK–mTOR Pathway Is Inhibited by Chaihu Shugan Powder, Which Relieves Nonalcoholic Steatohepatitis by Suppressing Autophagic Ferroptosis
by: Zheng Liang, et al.
Published: (2024-01-01)

Differential Expression Profiles of mRNA and Noncoding RNA and Analysis of Competitive Endogenous RNA Regulatory Networks in Nonalcoholic Steatohepatitis
by: Mengjia Gao, et al.
Published: (2022-01-01)

MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice
by: Jun Hu, et al.
Published: (2022-01-01)

Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations
by: Alia Hadefi, et al.
Published: (2025-01-01)

Targeted Plasma Bile Acid Metabolomic Analysis in Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Hepatitis
by: Yuta Hirata, et al.
Published: (2024-12-01)

Prevalence of Nonalcoholic Steatohepatitis and Associated Fibrosis Stages Among US Adults Using Imaging-Based vs Biomarker-Based Noninvasive Tests
by: Jesse Fishman, et al.
Published: (2024-02-01)

A mutation in LXRα uncovers a role for cholesterol sensing in limiting metabolic dysfunction-associated steatohepatitis
by: Alexis T. Clark, et al.
Published: (2025-01-01)

Verification of the Nutritional and Dietary Factors Associated with Skeletal Muscle Index in Japanese Patients with Nonalcoholic Fatty Liver Disease
by: Takashi Himoto, et al.
Published: (2020-01-01)

Association between Dysfunctional Beliefs and Coping Strategy among Persons Suffering from Substance Use Disorder
by: Prosenjit Ghosh, et al.
Published: (2025-01-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Combination of autoimmune hepatitis to non-alcoholic steatohepatitis (Clinical case)
by: A. A. Driga, et al.
Published: (2010-11-01)

Investigation of non-alcoholic steatohepatitis in labidochromis caeruleus and xiphophorus hellerii
by: Mustafa Ünal Boyraz, et al.

Steatohepatitis-induced vascular niche alterations promote melanoma metastasis
by: Johannes Hoffmann, et al.
Published: (2025-01-01)

Advantages and Disadvantages of Hyperbaric Oxygen Treatment in Mice with Obesity Hyperlipidemia and Steatohepatitis
by: Koichi Tsuneyama, et al.
Published: (2011-01-01)

Effects of celastrol on the heart and liver galaninergic system expression in a mouse model of Western-type diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis
by: Nikolina Canová, et al.
Published: (2025-02-01)

Aberrant Hepatic Methionine Metabolism and Gene Methylation in the Pathogenesis and Treatment of Alcoholic Steatohepatitis
by: Charles H. Halsted, et al.
Published: (2012-01-01)

Ethanol extract of Polygonatum cyrtonema Hua mitigates non-alcoholic steatohepatitis in mice
by: Dongliang Chen, et al.
Published: (2025-01-01)

Performance Assessment of Multiple Classifiers Based on Ensemble Feature Selection Scheme for Sentiment Analysis
by: Monalisa Ghosh, et al.
Published: (2018-01-01)

Skeletal Muscle Physiology
by: Lucas Guimarães-Ferreira, et al.
Published: (2013-01-01)

High-quality instant black tea manufactured using fresh tea leaves by two-stage submerged enzymatic processing
by: Junhao Kong, et al.
Published: (2022-05-01)

Acyl-CoA Thioesterase 1 Contributes to Transition of Steatosis to Metabolic-Associated Steatohepatitis
by: Elisa Pasini, et al.
Published: (2024-01-01)